7 relations: Buruli ulcer, Daiichi Sankyo, International nonproprietary name, Japan, Levofloxacin, Ofloxacin, Quinolone antibiotic.
Buruli ulcer
Buruli ulcer is an infectious disease caused by Mycobacterium ulcerans.
New!!: Sitafloxacin and Buruli ulcer · See more »
Daiichi Sankyo
is a global pharmaceutical company and the second largest pharmaceutical company in Japan.
New!!: Sitafloxacin and Daiichi Sankyo · See more »
International nonproprietary name
The International Nonproprietary Name (INN) is an official generic and non-proprietary name given to a pharmaceutical drug or an active ingredient.
New!!: Sitafloxacin and International nonproprietary name · See more »
Japan
Japan (日本; Nippon or Nihon; formally 日本国 or Nihon-koku, lit. "State of Japan") is a sovereign island country in East Asia.
New!!: Sitafloxacin and Japan · See more »
Levofloxacin
Levofloxacin, sold under the trade names Levaquin among others, is an antibiotic.
New!!: Sitafloxacin and Levofloxacin · See more »
Ofloxacin
Ofloxacin is an antibiotic useful for the treatment of a number of bacterial infections.
New!!: Sitafloxacin and Ofloxacin · See more »
Quinolone antibiotic
A quinolone antibiotic is any member of a large group of broad-spectrum bactericides that share a bicyclic core structure related to the compound 4-quinolone.
New!!: Sitafloxacin and Quinolone antibiotic · See more »
Redirects here:
ATC code J01MA21, ATCvet code QJ01MA21, DU-6859a.